Lu Wang

Lu Wang

Auto-generated profile, based on publicly available information

Lu Wang

Department of Neurosciences, University of California, San Diego, La Jolla, CA, 92093, USA; Rady Children's Hospital, San Diego, CA, 92123, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 August 2023 in Neuropharmacology
Verified
Journal Article
Closed access
HYHang Yao
Hang Yao
DHDaisy Hu
Daisy Hu
JWJuan Wang
Juan Wang
WWWei Wu
Wei Wu
HZHelen H. Zhao
Helen H. Zhao
GHGabriel G. Haddad
Gabriel G. Haddad

3 November 2025 in Cell Stem Cell
Verified
Journal Article
Closed access
LWLu Wang
Lu Wang
YNYuji Nakamura
Yuji Nakamura
JLJunhao Li
Junhao Li
DSDavid Sievert
David Sievert
YLYang Liu
Yang Liu
JGJoseph G. Gleeson
Joseph G. Gleeson

20 January 2023 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
LWLu Wang
Lu Wang
CHCaleb Heffner
Caleb Heffner
KVKeng Ioi Vong
Keng Ioi Vong
CBChelsea Barrows
Chelsea Barrows
YHYoo-Jin Ha
Yoo-Jin Ha
JGJoseph G. Gleeson
Joseph G. Gleeson
TMEM161B encodes an evolutionarily conserved widely expressed novel 8-pass transmembrane protein of unknown function in human. Here we identify TMEM161B homozygous hypomorphic missense variants in our recessive polymicrogyria (PMG) cohort. Patients carrying TMEM161B mutations exhibit striking neocortical PMG and intellectual disability. Tmem161b knockout mice fail to develop midline hemispheric cleavage, whereas knock-in of patient mutations and patient-derived brain organoids show defects in apical cell polarity and radial glial scaffolding. We found that TMEM161B modulates actin filopodia, functioning upstream of the Rho-GTPase CDC42. Our data link TMEM161B with human PMG, likely regulating radial glia apical polarity during neocortical development.

9 February 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
LWLu Wang
Lu Wang
DSDavid Sievert
David Sievert
ACAlex E. Clark
Alex E. Clark
HFHannah Federman
Hannah Federman
BGBenjamin D. Gastfriend
Benjamin D. Gastfriend
JGJoseph Gleeson
Joseph Gleeson
Clinical evidence suggests the central nervous system (CNS) is frequently impacted by SARS-CoV-2 infection, either directly or indirectly, although mechanisms remain unclear. Pericytes are perivascular cells within the brain that are proposed as SARS-CoV-2 infection points 1 . Here we show that pericyte-like cells (PLCs), when integrated into a cortical organoid, are capable of infection with authentic SARS-CoV-2. Prior to infection, PLCs elicited astrocytic maturation and production of basement membrane components, features attributed to pericyte functions in vivo. While traditional cortical organoids showed little evidence of infection, PLCs within cortical organoids served as viral ‘replication hubs’, with virus spreading to astrocytes and mediating inflammatory type I interferon transcriptional responses. Therefore, PLC-containing cortical organoids (PCCOs) represent a new ‘assembloid’ model 2 that supports SARS-CoV-2 entry and replication in neural tissue, and PCCOs serve as an experimental model for neural infection.

13 September 2025 in bioRxiv
Verified
Preprint
Open access
LWLu Wang
Lu Wang
YNYuji Nakamura
Yuji Nakamura
JLJunhao Li
Junhao Li
DSDavid Sievert
David Sievert
YLYang Liu
Yang Liu
JGJoseph G. Gleeson
Joseph G. Gleeson
SUMMARY: Thousands of genes are associated with neurodevelopmental disorders (NDDs), yet mechanisms and targeted treatments remain elusive. To fill these gaps, we present a CIRM-initiated NDD biobank of 352 publicly-available genetically-diverse patient-derived iPSCs, along with clinical details, brain imaging and genomic data, representing four major categories of disease: microcephaly (MIC), polymicrogyria (PMG), epilepsy (EPI), and intellectual disability (ID). From 35 representative patients, we studied over 6000 brain organoids for histology and single cell transcriptomics. Compared with an organoid library from ten neurotypicals, patients showed distinct cellular defects linked to underlying clinical disease categories. MIC showed defects in cell survival and excessive TTR+ cells, PMG showed intermediate progenitor cell junction defects, EPI showed excessive astrogliosis, and ID showed excessive generation of TTR+ cells. Our organoid atlas demonstrates both conserved and divergent NDD category-specific phenotypes, bridging genotype and phenotype. This NDD iPSC biobank can support future disease modeling and therapeutic approaches. HIGHLIGHTS: Resource of 352 CIRM-funded genetically-diverse IPSC lines from patients with neurodevelopmental disorders (NDDs). Genome/exome and brain images available for these genetically-diverse IPSC lines. Derived human brain organoids (hBOs) show disease-specific histological and cellular phenotypes. hBO phenotypes show unanticipated differentiation towards non-neuronal cell fates in NDDs.